Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Diltiazem

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 93Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of September 6, 2023
    Enforcement Report - Week of September 6, 2023

    06 Sep 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-6-2023-36272.pdf

    FDA
    06 Sep 2023
    Share Share
    Marcan Pharmaceuticals Inc. Product Recall (2020-09-18)
    Marcan Pharmaceuticals Inc. Product Recall (2020-09-18)

    21 Sep 2020

    // HEALTHY CANADIANS

    https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/73965r-eng.php

    HEALTHY CANADIANS
    21 Sep 2020
    Share Share
    Health Canada Issues Recall of Marcan Canada`s Mar-Diltiazem CD
    Health Canada Issues Recall of Marcan Canada`s Mar-Diltiazem CD

    20 Sep 2020

    // HEALTH CANADA

    https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-marcan-canadas-mar-diltiazem-cd-1600836246.pdf

    HEALTH CANADA
    20 Sep 2020
    Share Share
    Enforcement Report - Week of May 1, 2019
    Enforcement Report - Week of May 1, 2019

    01 May 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-1-2019-1556686753.pdf

    FDA
    01 May 2019
    Share Share
    Enforcement Report - Week of February 27, 2019
    Enforcement Report - Week of February 27, 2019

    27 Feb 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-27-2019-1551242597.pdf

    FDA
    27 Feb 2019
    Share Share
    Actavis Laboratories, FL, Inc., Ongoing Class III recall of Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA --- NDC 62037-0600-90 because of Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell
    Actavis Laboratories, FL, Inc., Ongoing Class III recall of Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA --- NDC 62037-0600-90 because of Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell

    22 Apr 2015

    // FDA

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0488-2015&w=04222015&lang=eng

    FDA
    22 Apr 2015
    Share Share